29 August, 2017
Webster Bank N.A. increased its stake in Walgreens Boots Alliance by 18.4% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator's stock worth $120,000 after buying an additional 975 shares during the period.
Walgreen Boots Alliance (NDAQ:WBA) had its target price reduced to $77.00 by Goldman Sachs Group Inc. Finally, Trust Investment Advisors increased its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter.
Walgreens Boots Alliance, Inc.is a holding company. Swiss National Bank now owns 3,262,703 shares of the pharmacy operator's stock valued at $270,967,000 after buying an additional 700,400 shares in the last quarter.
Co-COO, Barra Ornella, purchased 124,000 common shares of Walgreens Boots Alliance, Inc. Of those analysts, 9 rate stock as a Strong Buy, 2 rate it as Hold, and just no analyst rates it as a Moderate Sell. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory. The institutional investor owned 4,990 shares of the pharmacy operator's stock at the end of the first quarter.
Oarsman Capital Inc. boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares are on our watchlist today as the stock has moved -0.20% from the recent close, pricing at $81.16 at the time of press. Why are the underperforming company shares going higher?
Whereas they predicted High and Low Earnings Estimate as $1.25 and $1.15 respectively. The average analysts gave this company a mean recommendation of 2.00. The stock has a 50-day moving average price of $79.95 and a 200-day moving average price of $82.28.
(NASDAQ:WBA), maintained return on investment for the last twelve months at -, higher than what Reuters data shows regarding industry's average.
23 analysts on average are expecting Walgreens Boots Alliance, Inc.to report earnings of $1.3 per share for the current quarter. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road. While in the same Quarter Previous year, the Actual EPS was $1.07.
After a recent check, shares of Walgreens Boots Alliance, Inc. The total number of shares traded in the last 12 months is 2.37 million. This repurchase authorization allows the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. The company has Beta Value of 1.25 and ATR value of 1.14.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, August 16th. This is an increase from Walgreens Boots Alliance's previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%. Walgreens Boots Alliance's dividend payout ratio is now 40.30%.
TRADEMARK VIOLATION NOTICE: "Walgreens Boots Alliance, Inc". If you are reading this report on another publication, it was stolen and reposted in violation of United States and worldwide copyright and trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2017/08/29/walgreens-boots-alliance-inc-wba-shares-bought-by-principal-financial-group-inc.html.
Several analysts have recently commented on WBA shares. The "percentage off the 52-week high or low" refers to when a stock current price is relative to where it has traded over the last 52 weeks. Finally, Credit Suisse Group reiterated a "buy" rating and set a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fifteen have given a buy rating to the company. Price Target plays a critical role when it comes to the analysis of a Stock.
In related news, Director William C. Foote sold 2,736 shares of the company's stock in a transaction dated Tuesday, July 25th.
In the transaction dated February 02, 2017, the great number of shares acquired came courtesy the Director; Babiak Janice M. added a total of 600 shares at an average price of $80.68, amounting to approximately $48,408. The fund owned 8,350 shares of the pharmacy operator's stock after selling 100 shares during the period. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses.